This comprehensive PT-141 FAQ addresses technical, analytical, and practical questions for laboratory personnel conducting preclinical investigations into melanocortin receptor activation. From receptor selectivity and HPLC characterization to reconstitution protocols and endotoxin limits, this guide outlines essential standards for high-purity research applications.
This comprehensive PT-141 FAQ addresses technical, analytical, and practical questions for laboratory personnel conducting preclinical investigations into melanocortin receptor activation. From receptor selectivity and HPLC characterization to reconstitution protocols and endotoxin limits, this guide outlines essential standards for high-purity research applications.
PT-141, also known structurally as bremelanotide, is a synthetic cyclic heptapeptide analog derived from alpha-melanocyte-stimulating hormone (α-MSH). In preclinical models, researchers utilize PT-141 primarily to investigate central nervous system signaling mediated through the melanocortin receptor family. Unlike peripheral vasodilator compounds, PT-141 exerts its physiological effects upstream within central neuronal pathways.
Grounding data establish that PT-141 functions as a potent melanocortin agonist. It is widely investigated for melanocortin-receptor signaling linked to sexual-health pathways, neuroprotection, and neuroinflammatory regulation in rodent and non-human primate models. Understanding its receptor specificity and structural stability is critical for designing reproducible in vitro bioassays and in vivo preclinical protocols.
Chemically designated as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, PT-141 possesses a cyclic core stabilized by a lactam bridge between the Asp and Lys residues. This structural constraint confers enhanced resistance against enzymatic degradation compared to linear α-MSH peptides, making it an optimal candidate for prolonged benchtop characterization.
Preclinical binding studies indicate that PT-141 acts as a high-affinity agonist at melanocortin-3 receptors (MC3R) and melanocortin-4 receptors (MC4R), while displaying moderate binding affinity at MC1R and minimal activity at MC5R. In vitro binding assays demonstrate that activation of MC4R in hypothalamic sub-regions mediates downstream dopaminergic and oxytocinergic pathways, providing a rich framework for neuroendocrine research in the PX1 Research library hub.
When designing comparative bioassays, researchers frequently evaluate PT-141 alongside related synthetic peptides within the melanocortin class. While Melanotan-2 shares a cyclic structure and activates similar receptor subtypes, it exhibits significantly higher affinity for MC1R, driving pronounced melanogenesis in animal models. Conversely, Afamelanotide (Melanotan-1) functions as a linear α-MSH analog with high MC1R selectivity, making it less suitable for investigating central MC4R-mediated physiological pathways.
In contrast, PT-141 displays a more targeted binding profile geared toward central MC3R and MC4R signaling without inducing the predominant peripheral melanogenic activity observed in earlier-generation compounds. Reviewing our technical breakdown on melanocortin agonists provides further comparative binding constants and receptor dynamics for structural analyses.
Reproducibility in scientific literature depends directly on chemical purity. Low-grade peptides containing truncated fragments or deletion sequences introduce confounding variables into receptor binding and cell culture experiments. PX1 Research subjects every batch of PT-141 to rigorous analytical validation via high-performance liquid chromatography (HPLC) and mass spectrometry (MS).
An analytical High-Performance Liquid Chromatography chromatogram must confirm a purity threshold exceeding 99.0%, with a sharp, well-defined main peak and absence of major synthesis side-products. Concurrently, Electrospray Ionization Mass Spectrometry (ESI-MS) confirms the exact theoretical molecular weight of 1024.2 Da. Every lot supplied by PX1 Research includes a comprehensive, downloadable Certificate of Analysis (COA) generated by an independent, ISO 17025 accredited laboratory.
Bacterial endotoxins (lipopolysaccharides) pose a significant risk in cellular assays and animal administration models. Even trace endotoxin contamination can trigger non-specific inflammatory responses via Toll-like receptor 4 (TLR4), masking true melanocortin receptor-mediated outcomes and compromising experimental integrity.
All PT-141 batches distributed by PX1 Research undergo rigorous Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain strictly below < 0.01 EU/mg. Furthermore, production takes place in USA-based, GMP-compliant facilities utilizing state-of-the-art sterile processing equipment to guarantee pristine chemical integrity for demanding in vitro and in vivo models.
Lyophilized PT-141 should be stored at -20°C or -80°C upon receipt to maintain long-term stability. The lyophilized cake is stable for up to 24 months under desiccated, sub-zero conditions. Prior to opening the vial, allow it to equilibrate to room temperature to prevent condensation of ambient moisture inside the container.
For reconstitution, laboratory technicians should utilize sterile bacteriostatic water (containing 0.9% benzyl alcohol) or sterile endotoxin-free phosphate-buffered saline (PBS), depending on the requirements of the downstream protocol. Gently swirl or invert the vial until full dissolution occurs; mechanical vortexing should be avoided as high shear force can cause peptide aggregation or denaturation. Detailed protocols are available in our peptide reconstitution guide.
Principal investigators and procurement directors requiring scalable supply chains can utilize PX1 Research’s dedicated institutional channels. We maintain continuous inventory in domestic distribution centers located in California and Arizona, enabling same-day dispatch for orders finalized before 12:00 PM PST Monday through Friday.
Academic departments and corporate research facilities requiring bulk quantities, custom vial fill sizes, or specific lot reservation contracts can establish dedicated accounts through our wholesale laboratory program. Every shipment is packaged with thermal insulation to safeguard structural integrity during transit.
What is PT-141 and what is its primary biological mechanism?
PT-141 (bremelanotide) is a synthetic cyclic peptide agonist targeting the melanocortin receptor system. Preclinical studies indicate that its primary mechanism involves binding to central MC3R and MC4R subtype receptors within the hypothalamus, modulating neuroendocrine signaling pathways linked to physiological function and inflammation.
How does PT-141 differ from Melanotan-2 (MT-2)?
While both are cyclic α-MSH derivatives, PT-141 lacks the potently active terminal group that drives intense peripheral MC1R activation in Melanotan-2. Consequently, PT-141 is primarily investigated for central melanocortin-4 receptor pathways rather than peripheral pigmentation or melanogenesis pathways.
What purity level does PX1 Research guarantee for PT-141?
PX1 Research guarantees a minimum purity of 99.0% for every lot of PT-141. Purity is verified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Mass Spectrometry (MS) conducted by an independent ISO 17025 accredited laboratory.
What endotoxin limits are verified for PX1 Research peptides?
Every lot of PT-141 is subjected to quantitative LAL endotoxin testing and verified to contain less than 0.01 EU/mg of bacterial endotoxins, preventing confounding inflammatory responses in cell culture or animal research models.
How should lyophilized PT-141 be stored upon delivery?
Lyophilized PT-141 should be stored desiccated at -20°C for short-to-medium term storage, or at -80°C for extended stability exceeding 12 months. Exposure to moisture, direct light, and elevated temperatures should be strictly avoided.
What solvent is recommended for reconstituting PT-141 in lab settings?
Reconstitution is typically performed using sterile bacteriostatic water (0.9% benzyl alcohol) for repeated sampling protocols, or sterile endotoxin-free PBS for immediate biological assays. Gentle inversion is recommended to avoid mechanical shearing.
How long remains reconstituted PT-141 stable at refrigerated temperatures?
When reconstituted in sterile bacteriostatic solvent and stored at 2°C to 8°C, PT-141 maintains functional stability for up to 30 days. Reconstituted aliquots stored without preservatives should be used immediately or frozen once at -20°C to prevent degradation.
Are Certificates of Analysis (COAs) provided with each batch?
Yes. PX1 Research provides lot-specific Certificates of Analysis with every shipment. COAs confirm raw purity percentage, identity via mass spectrum peak matching, and endotoxin assay results from an independent third-party lab.
Can PT-141 be used for human treatment or medical therapy?
No. PT-141 supplied by PX1 Research is strictly designated as a research compound for laboratory research use only. It is not intended for human or animal consumption, clinical administration, therapy, or diagnostic applications.
Where are PX1 Research peptides synthesized and shipped from?
All PX1 Research compounds are synthesized in USA-based, GMP-compliant facilities. Orders are fulfilled and shipped directly from our primary logistics hubs in California and Arizona, featuring same-day dispatch Monday through Friday.
What other melanocortin or neuroendocrine research peptides are available?
PX1 Research supplies a wide range of analytical-grade signaling compounds, including [Melanotan-2](/product/melanotan-2), [Afamelanotide](/product/afamelanotide), and tissue-repair agents like [BPC-157](/research-peptides/bpc-157).
How do institutional buyers set up bulk procurement accounts?
Academic institutions, corporate labs, and principal investigators can submit an account application through our [wholesale portal](/wholesale) to access volume tier pricing, reserved single-lot production runs, and direct account manager support.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.